Union defence minister Rajnath Singh today released the first batch of the anti-Covid-19 drug, 2-deoxy-D-glucose (2-DG), which has been granted emergency approval by the Drug Controller General of India (DCGI). The anti-Covid oral drug has been developed by the Defence Research and Development Organisation’s (DRDO’s) leading laboratory — Institute of Nuclear Medicine and Allied Sciences (INMAS) — in collaboration with Dr Reddy’s Laboratories.
Releasing the drug along with Health Minister Harsh Vardhan, Defence Minister Rajnath Singh said 2-deoxy-D-glucose (2-DG) has brought a “new ray of hope” in the treatment of COVID-19 patients.
The Drugs Controller General of India (DGCI) approved 2-DG for emergency use as an adjunct therapy in moderate to severe coronavirus patients earlier this month.
The defence ministry, on May 8, said the clinical trials of 2-DG showed that it helps in a faster recovery of hospitalised patients and reduces the supplemental oxygen dependence.